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Abstract
Contrast-enhanced micro-computed tomography (CEμCT) with phosphotungstic acid (PTA)
has shown potential for detecting collagen distribution of articular cartilage. However, the
selectivity of the PTA staining to articular cartilage constituents remains to be elucidated.
The aim of this study was to investigate the dependence of PTA for the collagen content in
bovine articular cartilage. Adjacent bovine articular cartilage samples were treated with
chondroitinase ABC and collagenase to degrade the proteoglycan and the collagen constit-
uents in articular cartilage, respectively. Enzymatically degraded samples were compared
to the untreated samples using CEμCT and reference methods, such as Fourier-transform
infrared imaging. Decrease in the X-ray attenuation of PTA in articular cartilage and collagen
content was observed in cartilage depth of 0–13% and deeper in tissue after collagen degra-
dation. Increase in the X-ray attenuation of PTA was observed in the cartilage depth of 13–
39% after proteoglycan degradation. The X-ray attenuation of PTA-labelled articular carti-
lage in CEμCT is associated mainly with collagen content but the proteoglycans have a
minor effect on the X-ray attenuation of the PTA-labelled articular cartilage. In conclusion,
the PTA labeling provides a feasible CEμCT method for 3D characterization of articular
cartilage.
Introduction
Composition of articular cartilage (AC) is known to be strongly associated with its biomechan-
ical properties [1]. Main constituents in AC are proteoglycans (PG), collagens and chondro-
cytes. Osteoarthritis (OA) progression leads to loss of PG content, degeneration of collagen
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network with perichondronal collagen condensation, and focal intra matrix collagen forma-
tion, all resulting in a progressive heterogeneity of cartilage matrix and a deterioration of AC
biomechanical properties [2]. Therefore, investigation of the histologic distribution and micro-
architectural changes of these macromolecular constituents is important for understanding
OA progression.
Contrast-enhanced micro-computed tomography (CEμCT) enables high-resolution 3D
characterization of soft tissues [3] including AC [4]. Several studies have shown the potential
of CEμCT to quantify the PG content and distribution in the AC both in vitro and in vivo [5–
10]. These studies utilize either negatively charged (Hexabrix1, Magnevist1) or positively
charged (CA1+, CA2+, CA4+ and Tantalum Oxide Nanoparticles) contrast agents to produce
contrast in the AC. Hexabrix1 and Magnevist1 are also in clinical use to detect the loss of
PGs [11,12]. However, it can be debated whether the decrease in the PG content is primarily
followed by changes in the collagen integrity. For example, the swelling of the AC resulting
from the collagen degradation, can lead to ostensible PG loss [13,14]. Consequently, novel
methods, which are able to specifically quantify the constituents of the AC in the micro-level,
are needed to understand the disease progression and improve the diagnostics of OA.
In our previous study, we reported the potential of CEμCT method for analyzing the 3D
collagen distribution in AC by using phosphotungstic acid (PTA) as the contrast agent [4].
The low pH of the PTA solution (2.71) enables the binding of the negatively charged PTA to
the collagen, which has a positive net charge in low pH [15]. Since PGs have a small negative
charge in the same pH range[15], it is reasonable to assume that the PGs may restrict the PTA
binding to the collagen in the AC by means of electrostatic repulsion. Furthermore, the actual
specificity of the PTA labeling used in CEμCT for the collagen in the presence and absence of
PGs in the AC is not known. Previously, it has been shown that enzymatic digestion of PGs
increases Hexabrix1 (ioxaglic acid) diffusion into the cartilage, thus, increasing the cartilage
X-ray attenuation in the CECT imaging [16,17]. Similarly to the PTA, the ioxaglic acid is also
negatively charged, and its ability to reveal the PG distribution in AC relies on the repulsion by
the charge of PGs. Ioxaglic acid also differs from the PTA by the weaker negative charge.
Because the Hexabrix1 is tailored for clinical applications, it is dissolved in a solution, which
has pH of approximately 7.4, where the net charge of the collagen is close to zero [15]. There-
fore, there is likely no electrochemical attraction between the negatively-charged ioxaglic acid
and the collagen network of AC.
The aim of this study was to investigate the specificity of the PTA for the collagen content
and distribution in bovine AC in the CEμCT setting by enzymatically degrading either the col-
lagen or the PGs. The enzymatic degradations were validated using Fourier-transform infrared
imaging (FTIRI), histology and biochemical analyses for the contents of the collagen and the
PGs [18,19]. Furthermore, PTA distribution in AC was compared with Hexabrix1 distribu-
tion in CEμCT settings. Our hypothesis was that the binding of the PTA is strongly affected by
collagen degradation, while the degradation of the PGs has only a minor effect on the PTA
binding.
Materials and Methods
Sample Preparation
Right hind limbs from bovines (N = 9) were acquired from the local abattoir (Veljekset Ro¨nka¨
Oy, Kemi, Finland) and stored in a freezer (-20˚C) until experiments. After thawing, three
adjacent cylindrical osteochondral plugs (diameter = 4.8 mm) were drilled from the lateral
upper quadrant of each patella and divided into (i) collagenase, (ii) chondroitinase ABC and
(iii) control (untreated) groups, respectively (Fig 1). Before enzymatic treatments, each plug
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was cut into four pieces. The first and the second pieces were subjected to CEμCT using the
PTA and the Hexabrix1 as contrast agents, respectively. The third and fourth pieces were
used for reference techniques, which included histology, Fourier Transform Infrared Imaging
(FTIRI) and biochemistry.
Enzymatic degradations
Chondroitinase ABC (Sigma-Aldrich, St. Louis, MO, C3667; 0.1 U/ml, 44 h at 37˚C, 5% CO2)
in phosphate-buffered saline (PBS, pH 7.4) and collagenase (Sigma-Aldrich, C0773; 30 U/ml,
50 h at 37˚C, 5% CO2) in PBS (pH 7.4) were used to degrade chondroitin/dermatan sulfate
and hyaluronan glycosaminoglycans (GAGs), and the collagens, respectively [20]. The control
samples were directly subjected to CEμCT, histology, FTIRI and biochemical analyses.
CEμCT
After enzymatic treatments, samples for the PTA labeling were first fixed in 10% neutral-buff-
ered formalin for 5 days and transferred to 70% ethanol for 8 hours followed by 36 h immer-
sion in the 1% w/v PTA solution (Sigma-Aldrich, 79690) in 70% ethanol. The PTA labelling
protocol was same for the adjacent control samples. The PTA labelled samples were wrapped
in cellulose and immersed in a sealed container filled with 70% ethanol. The other set of the
CEμCT samples were immersed after the enzymatic treatment in 10% Hexabrix1 320 (Mal-
linckrodt Pharmaceuticals Inc., St. Louis, MO, USA) in PBS for 28 h and subjected to μCT
imaging inside a sealed container. Control samples for the CEμCT with Hexabrix1 were sub-
jected to the same protocol immediately after the core extraction. Due to the relatively fast
washout of the Hexabrix1, the container could not be filled with liquid. To prevent the drying
of the sample during the scan, moistened cellulose was added on the bottom of the container
to raise the humidity inside the container.
The CEμCT scanning was conducted with the Skyscan 1176 (Bruker microCT, Kontich,
Belgium; settings: 40 kV, 600 μA, 1200 projections, exposure 200 ms/frame, average of 2
frames per projection, isotropic voxel side length 17.4 μm, without additional filtration).
Reconstructions for X-ray projections were made with the manufacturer’s Skyscan Nrecon-
software (v. 1.6.9, Bruker microCT). Ring artefact and beam hardening corrections were
applied in the reconstruction.
For statistical analyses, depth-wise profiles were calculated from the reconstructed CEμCT
image stacks (Fig 1). Depth-wise profiles were generated from 3D datasets with Matlab R2014a
software (v. 8.3.0.532, Mathworks, Natick, MA, United States) (Fig 1). Prior to generating the
depth-wise profiles, 3D image stacks were rotated so that cartilage surface and uncalcified car-
tilage-CC interface were oriented horizontally in the image stack. To prevent possible artifacts
on the edges of the plugs (from the preparation and enzymatic treatment) affecting the depth-
wise analysis, z-direction was restricted to 20 voxels (20 slices from reconstructed stack, see Fig
1). Datasets were processed slice-by-slice (pseudo-3D), and the generation of the depth-wise
profiles consisted of three steps: cartilage surface and uncalcified cartilage-CC interface detec-
tion, depth-wise vector normalization and 2D profile generation, and 3D profile generation
and resampling. Interface detections were done by first applying a global threshold to binarize
the image and then detecting the depth-wise co-ordinates for the interface in each image col-
umn. Two separate global thresholds were used for cartilage surface and uncalcified cartilage-
CC interface. This simplified interface detection was possible because of the different Houns-
field unit (HU) values for calcified tissue (CC & bone) and PTA-stained cartilage in μCT imag-
ing. In the second step for generating the depth-wise profiles, the interfaces were straightened
as described in a previous study [4]. After straigthening the interfaces, the image rows were
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averaged and 2D profiles for each slice was generated. In the third step, the 2D profiles were
averaged by corresponding depth-wise co-ordinates throughout slices to generate the 3D
depth-wise profiles. These 3D depth-wise profiles were finally resampled to 100 datapoints.
For the enzymatic treated samples each datapoint (xEnz) was compared to the correspond-
ing datapoint in the control group (xcon). The comparison was done by calculating the relative
Fig 1. Preparation, grouping and analysis of the samples. Sample procedure is shown in the flow chart. Cylindrical (diameter = 6 mm) osteochondral
samples (n = 3) were collected from visually healthy patella of nine bovines, sectioned in pieces and divided into groups depending on their enzymatic
treatment. Pieces from each group were subjected to 1) contrast-enhanced computed micro-tomography (CEμCT) with phosphotungstic acid (PTA), 2)
CEμCT with Hexabrix®, 3) Fourier-transform infrared imaging (FTIRI) and histology, and 4) biochemical analyses. The generation of the depth-wise profiles
from CEμCT and FTIRI data consisted of three steps: 1) cartilage surface and the uncalcified cartilage-calcified cartilage (CC) interface detection, 2)
Straightening the interfaces and generation of 2D profiles for each image, 3) generation of the 3D profile by averaging corresponding depth-wise coordinates
throughout slices and resampling the depth-wise profile to 100 datapoints. FTIRI data was only resampled to 100 datapoints in the third step. For more
specific description of this process, see the Methods section. The CEμCT results were compared with the reference analyses (FTIRI, histology and
biochemical analyses).
doi:10.1371/journal.pone.0171075.g001
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change (see Eq 1) sample-by-sample and calculating the depth-wise means and standard devia-
tions for both comparison groups (collagenase vs. control, chondroitinase ABC vs. control).
Relative difference %ð Þ ¼ 100 
xEnz   xcon
xcon
ð1Þ
Histological analyses
To qualitatively evaluate the effectiveness of enzymatic degradations, 3 μm sections were pre-
pared for Picrosirius red and Safranin O [21] stains to determine the collagen and the GAG
distributions, respectively. The Picrosirius Red -staining protocol used in our study was modi-
fied from the standard protocol [22] by adding the purification step to demonstrate collagen
fibre patterns. This was conducted by 18 h immersion in 0.5% papain (Acros Organics,
416761000) in 0.05 M PBS (pH 4.4, 37˚C) and 1000 U/ml hyaluronidase (Sigma-Aldrich,
H3506) in 0.1 M PBS (pH 6.9, 37˚C) digestions before the staining with 0.1% Direct red 80 in
saturated picric acid (Sigma-Aldrich, 365548). Polarized light microscopy (PLM) was used to
measure the retardance caused by picrosirius red stain in the sections to reveal alterations in
the collagen content. The sections were imaged with Abrio polarized light imaging system
(CRi, Inc., Woburn, MA, USA) mounted on a light microscope (Nikon Diaphot TMD, Nikon,
Inc., Shinagawa, Tokyo, Japan).
FTIRI analyses
The unstained microscopic sections (thickness = 5 μm) were imaged with Hyperion 3000
FTIRI Microscope (Bruker Inc., Billerica, MA, USA) with the following parameters: binning of
2 x 2, pixel size of 5.4 x 5.4 μm, spectral resolution of 8 cm-1, and 16 acquisitions per pixel. The
acquired spectral data were offset-normalized, and the integrated absorbances of the amide I
region (1595–1720 cm-1) and the carbohydrate region (985–1120 cm-1) were calculated to
indicate the distribution of the collagen and the GAGs, respectively [19,23]. Depth-wise pro-
files for FTIRI were generated similarly as in CEμCT analysis with slight modification as after
generating the 2D profile from single image, the profile was resampled to 100 datapoints with-
out further processing. The relative differences were calculated from the profiles similarly as
for the CEμCT profiles (see. Eq 1).
Uronic acid quantification
The pre-weighted samples were digested with papain (1 mg/ml in 5 mM cysteine and 5 mM
EDTA) overnight at 60˚C to solubilize the cartilage tissue. Uronic acid content was then deter-
mined [24], and the results were normalized by wet weight.
Proteoglycan structure analysis
The cartilage sections reserved for biochemical analyses were cut into smaller pieces, and the
PGs were extracted by immersing the samples in 4 M guanidinium hydrochloride in 50 mM
sodium acetate, 10 mM EDTA and 5 mM benzamidine hydrochloride (pH 5.8) at 4˚C for 72
hours. The amount of the PGs was determined with dimethylmethylene blue assay [25], and
the PGs (5 μg GAG) were separated in 1.2% agarose gels as described previously [26].
Statistical analyses
Depth-wise profiles from CEμCT and FTIRI were evaluated point-by-point with the 2-tailed
Wilcoxon signed-rank test (IBM SPSS Statistics software v. 21, International Business
Machines Corporation, Armonk, NY, U.S) by comparing the means of enzymatic degradation
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groups with the means of control group. The differences in the agarose gel profiles between
the control and the enzymatically treated ones were tested with the 2-tailed paired t-test.
To estimate the normal biological variation within the samples, coefficients of variation
(CV, ratio between the standard deviation and the mean) in the pixel/voxel values from the
control (untreated) samples through the tissue depth were calculated.
Results
The visual comparison between the CEμCT images of the PTA-labelled AC and histological stain-
ing for the collagen distribution in the AC (Picrosirius Red with PLM) was consistent (Fig 2). As
Fig 2. 2D-slices of PTA- and Hexabrix®-labelled ACs (CEμCT) compared to the corresponding histological collagen and PG stains. Birefringence of
Picrosirius red stain was imaged with polarized light microscopy (PLM) to visualize the collagen fibre content and distribution. The histological stains showed
clear effects of the enzymes, which can be seen as an insufficient staining in the surface of the sample as compared to the control samples (the depth of the
enzyme effect indicated with red arrows). The Picrosirius red stain and the PTA showed highly similar collagen distributions. Also Safranin O and Hexabrix®
showed highly similar PG distributions. Color-scaled Hounsfield unit (HU) -values of the CEμCT and retardance (nm) of PLM are presented in the bottom.
Different scalings between the PTA- and Hexabrix®-enhanced images were used to better visualize the distributions of the contrast agents in the cartilage.
Black arrows indicate the cartilage surface and the uncalcified cartilage-CC interface. Scale bars on the right corner of each sample equal to 500 μm.
doi:10.1371/journal.pone.0171075.g002
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expected, the visual comparison between the histological PG staining (Safranin O) and the X-ray
attenuation of PTA in AC did not correspond to each other. Comparison between the Safranin O
staining and the X-ray attenuation obtained from CEμCT of AC with PG-sensitive Hexabrix1
revealed the close correspondence between the ioxaglic acid distribution and the PG distribution.
The X-ray attenuation from CEμCT with Hexabrix1 did not have correlation with the Picrosir-
ius red staining.
A statistically significant decrease of 14–40% in the X-ray attenuation of PTA was observed
in the surface (p<0.05 in range of tissue depth 0–13%, see S1 Table for specific p-values
throughout the tissue) of the collagenase-degraded samples compared to the control group
(Fig 3). Smaller (9–10%), but a statistically significant decrease in the X-ray attenuation was
observed deeper in the tissue (tissue depth 48–63%). These results from μCT of PTA-stained
AC corresponded spatially with the collagen loss observed in the collagenase-digested speci-
mens by the FTIRI (amide I absorbance) analyses (Fig 3). Furthermore, the FTIRI analyses,
based on the carbohydrate region (Fig 3), showed a significant (p<0.05) decrease in the PGs in
the tissue depth of 0–77%. However, there was no statistically significant increase in X-ray
attenuation of Hexabrix1 in CEμCT (Fig 3).
After chondroitinase ABC degradation, statistically significant changes (p<0.05 in the tis-
sue depth of 13–39%) were also observed in the X-ray attenuation of PTA in AC even though
the FTIRI-based absorbance from the amide I peak (Fig 3) did not show statistically significant
changes between the groups. However, a significant decrease (p<0.05) in the FTIRI-based
Fig 3. The relative changes between the enzymatic treatment groups and the control (untreated) group. For depth-wise analyses (A-D), the tissue
depth was normalized, depth-wise profiles were calculcated and resampled to 100 points from CEμCT (in 3D) and FTIRI (in 2D). The relative change and
statistical differences were calculated point-by-point for both enzymatic treatments (see S1 Table for p-values throughout depth). Statistically significant
difference between enzymatically treated groups and control group was calculated with Wilcoxon signed-rank test. After collagenase treatment, decreasing
relative change in the X-ray attenuation obtained from PTA-stained AC (A) was significant in the surface and deeper layers of the tissue. Similar decrease
with the reference collagen content measured with FTIRI (amide I) (B) was observed in the same areas. After chondroitinase treatments, both CEμCT
techniques (A and C) had significant decrease in the X-ray attenuation in the middle layers of tissue (PTA: 13–39% of the tissue depth; Hexabrix®: 22–48%
of the tissue depth). Reference PG content measured with FTIRI (D) and uronic acid analysis (E) both indicated a significant decrease of PG content with
both enzymatic degradations.
doi:10.1371/journal.pone.0171075.g003
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absorbance for the carbohydrate region after PG degradation in the tissue depth 0–73% (Fig 3),
and a significant increase (p<0.05) in Hexabrix1-enhanced μCT attenuation was observed in
the tissue depth 22–48% (Fig 3). The uronic acid analysis confirmed the significant (chondroiti-
nase ABC: p = 0.001, collagenase: p = 0.019) loss of GAGs in both enzyme digestions (Fig 3).
Since the chondroitinase ABC and collagenase treatments led to practically similar loss of
GAGs from the tissue, we analysed the structures of the major PGs with agarose gel electro-
phoresis. The analysis showed a marked increase in the presence of diffuse higher mobility
PGs (Fig 4A), indicating a partial degradation of the large PGs (apparently aggrecans) by both
enzyme treatments. The average profiles of chondroitinase ABC (Fig 4B) and collagenase-
treated (Fig 4C) samples revealed significant differences in the staining patterns.
Additionally, the coefficient of variation (CV) in untreated group was calculated to provide
information about the biological variation between the samples. Biological sample-to-sample
variations in the X-ray attenuation of the PTA-labelled AC varied in range ~8–16% at different
tissue depths (untreated samples). Biological variations of Hexabrix1-enhanced μCT were in
similar range ~12–15%. In FTIRI analyses, corresponding biological variations were observed
to be higher varying from 14–26% in the amide I region and 16–22% in the carbohydrate
region throughout the depth of the tissue.
Discussion
The results of this study suggest that PTA distribution mainly coincides with the collagen con-
tent in the superficial AC and relies on the balance dictated by the electric attraction forces of
collagen and repulsion forces of the PGs within AC. The X-ray attenuation of PTA-labelled
AC in CEμCT was observed to decrease substantially (14–40%) in the more superficial layers
of the AC (tissue depth: 0–13%) after collagenase treatment and the distribution of PTA in AC
corresponded to the Picrosirius red-stained histological slices by visual inspection. FTIRI
showed more severe collagen degradation than the CEμCT with PTA suggested (difference of
~5–10% throughout the full tissue depth). However, the decrease in the amide I absorbance
corresponded spatially to the decrease in the X-ray attenuation of PTA-labelled AC in CEμCT
throughout the tissue depth. This confirms the hypothesis that the X-ray attenuation in the
PTA-enhanced μCT of AC is associated with the collagen content. Chondroitinase ABC treat-
ment did induce statistically significant changes of ~9–13% in the X-ray attenuation mainly in
the middle and deep zones of the tissue (13–39% of tissue depth) in the chondroitinase ABC
treated samples. Similar increase was observed in the Hexabrix1-labelled AC (Fig 3) after the
chondroitinase ABC degradation. This correspondence to another negative contrast agent and
the observed increase in the X-ray attenuation suggests that the PGs also have minor effect on
PTA labeling, thus confirming the latter part of the hypothesis.
Histological, FTIRI, and uronic acid analyses revealed clearly that the GAG content was
reduced also after the collagenase treatment. The structural analysis of PGs with agarose gel
electrophoresis indicated that large PGs were markedly degraded by the collagenase. In
human, there are 23 identified matrix metalloproteinases (MMPs), of which MMP-1, MMP-8,
MMP-13 and MMP-18 are collagenases that cleave the interstitial collagen, but also a number
of other extracellular matrix proteins [27]. The cleavage sites for collagenases have been identi-
fied previously for aggrecan [28] and link protein [29]. The bacterial collagenase from Chlos-
tridium histolyticum used in this study has wide substrate degradation specificity [30], which
suggests that it also is able to degrade bovine aggrecans, as supported by the agarose gel elec-
trophoresis analysis. The degradation of aggrecan population decreases their average size so
much that they can be expected to diffuse out of the tissue during the relatively long digestion
times. Chondroitinase ABC degrades the chondroitin/dermatan sulfate, which itself
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diminishes the Safranin O staining of the tissue. However, the ability of the enzyme to degrade
hyaluronan [31], liberating the aggrecan monomers, may have even bigger role for the loss of
GAGs from the tissue. Almost a complete loss of Safranin O staining in the superficial and the
middle zones of chondroitinase ABC-treated tissue suggests that keratan sulfate-containing
aggrecan monomers are no longer present in the AC. The simultaneous loss of collagens and
GAGs by the collagenase could be considered as the confounding factor for the minor, but
clear decrease of the X-ray attenuation in PTA-stained AC detected with μCT.
Fig 4. Structural analysis of PGs by agarose gel electrophoresis. Representative lanes of chondroitin sulfate (CS), and PGs extracted from the control
(Ctrl), chondroitinase ABC-treated (Cho) and collagenase-treated (Col) samples are shown (A). The mean profiles of the samples for control vs.
chondroitinase ABC-treated (B) and control vs. collagenase-treated (C) samples are shown. The migration distance of CS was set to reference value 1.00.
The paired t-test was used to estimate the difference in the staining profiles. Statistically significant differences (*) for chondroitinase ABC from left to right
were p = 0.0042, p = 0.0032, p = 0.0220; and for collagenase from left to right were p = 0.0001, p = 0.0315, p = 0.0220, p = 0.0308, p<0.001. Only a limited set
of standard deviations are shown for the clarity of the figure (n = 8).
doi:10.1371/journal.pone.0171075.g004
Effects of Articular Cartilage Constituents on PTA Enhanced Micro-CT
PLOS ONE | DOI:10.1371/journal.pone.0171075 January 30, 2017 9 / 12
Even though FTIRI, histology and uronic acid analyses clearly indicated presence of PG
degradation, statistically significant changes in the X-ray attenuation of Hexabrix1-labelled
AC after collagenase degradation was not observed. This suggests that high biological varia-
tion, determined from untreated samples, in CEμCT (CV of PTA: ~8–16%; and CV of Hexab-
rix1: ~12–15%) might affect the results by concealing the decrease or increase in X-ray
attenuation. This variation could also affect detecting the changes in the X-ray attenuation of
PTA-labelled AC in the deeper layers of the tissue, where the decrease in the attenuation is not
statistically significant.
Regarding the suggested use of PTA labeling of AC in CEμCT for 3D histological evaluation
of OA [4], the charactestics of PTA by revealing information on both PGs and collagen could
be advantageous when determing the stage of OA in vitro. Especially if PG loss preceeds the
changes of collagen matrix [2], the PTA-labelled AC in CEμCT could be used to determine
changes not only on the integrity of the collagen matrix but also on the PG depletion.
In conclusion, the X-ray attenuation of PTA-labelled AC in CEμCT is associated mainly
with the collagen content, whereas the PGs have minor effect on the X-ray attenuation of the
PTA-labelled AC. PTA labeling of AC in CEμCT could provide a feasible tool for 3D histologi-
cal evaluation of the OA.
Supporting Information
S1 Table. Data from depth-wise analyses and statistical tests. Means of the groups (n = 9),
standard deviations, and relative changes between enzymatically treated groups and control
group are shown in the table. Wilcoxon signed-rank test was used to determine if there were
statistically significant difference between the groups. Statistical tests for each depth value was
calculated separately and p-values less than 0.05 are bolded in the table.
(XLSX)
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